1. Du, Bingxin, Jia, Xinhui, Tian, Wenqi, Qiu, Changchun, Zhang, Qi. 2020. Associations of SUCNR1, GRK4, CAMK1D gene polymorphisms and the susceptibility of type 2 diabetes mellitus and essential hypertension in a northern Chinese Han population. In Journal of diabetes and its complications, 35, 107752. doi:10.1016/j.jdiacomp.2020.107752. https://pubmed.ncbi.nlm.nih.gov/33127268/
2. Volpin, Valentina, Michels, Tillmann, Sorrentino, Antonio, Khandelwal, Nisit, Beckhove, Philipp. 2020. CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment. In Cancer immunology research, 8, 1163-1179. doi:10.1158/2326-6066.CIR-19-0608. https://pubmed.ncbi.nlm.nih.gov/32665263/
3. Liu, Wei, Li, Shan. 2021. LncRNA ILF3-AS1 Promotes the Progression of Colon Adenocarcinoma Cells Through the miR-619-5p/CAMK1D Axis. In OncoTargets and therapy, 14, 1861-1872. doi:10.2147/OTT.S296441. https://pubmed.ncbi.nlm.nih.gov/33737811/
4. Sui, M-H, Zhang, W-W, Geng, D-M, Sun, D-J. . CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D. In European review for medical and pharmacological sciences, 25, 1899-1909. doi:10.26355/eurrev_202102_25085. https://pubmed.ncbi.nlm.nih.gov/33660800/
智鼠故事 
